{"id":"https://openalex.org/W7204988160","doi":"https://doi.org/10.3390/ijms27209083","title":"TLR2 Signaling in Myeloproliferative Neoplasms: Pathophysiological Roles, Mutation-Dependent Heterogeneity, and the Differential Efficacy of Ruxolitinib","display_name":"TLR2 Signaling in Myeloproliferative Neoplasms: Pathophysiological Roles, Mutation-Dependent Heterogeneity, and the Differential Efficacy of Ruxolitinib","publication_year":2026,"publication_date":"2026-10-13","ids":{"openalex":"https://openalex.org/W7204988160","doi":"https://doi.org/10.3390/ijms27209083","pmid":"https://pubmed.ncbi.nlm.nih.gov/42941857","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13705039"},"language":"en","primary_location":{"id":"doi:10.3390/ijms27209083","doi":"https://doi.org/10.3390/ijms27209083","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ijms27209083","pdf_url":null,"source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/ijms27209083","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090726575","display_name":"Akriti Pokhrel","orcid":"https://orcid.org/0000-0002-6628-1875","observed_orcids":["https://orcid.org/0000-0002-6628-1875"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akriti Pokhrel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6628-1875","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051807502","display_name":"Narek Hakobyan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Narek Hakobyan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5009218109","display_name":"Jen Chin C. Wang","orcid":"https://orcid.org/0000-0002-9623-6645","observed_orcids":["https://orcid.org/0000-0002-9623-6645"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jen Chin Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9623-6645","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5009218109"],"corresponding_institution_ids":[],"apc_list":{"value":2900,"currency":"CHF","value_usd":3499},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3499},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.60505818,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"20","first_page":"9083","last_page":"9083"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tlr2","display_name":"TLR2","score":0.9589999914169312},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9890000224113464},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9070000052452087},{"id":"https://openalex.org/keywords/thromboinflammation","display_name":"thromboinflammation","score":0.7080000042915344},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.8029999732971191},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.9440000057220459},{"id":"https://openalex.org/keywords/jak2-mutation","display_name":"JAK2 mutation","score":0.8420000076293945},{"id":"https://openalex.org/keywords/calr-mutation","display_name":"CALR mutation","score":0.9959999918937683},{"id":"https://openalex.org/keywords/essential-thrombocythemia","display_name":"essential thrombocythemia","score":0.9559999704360962},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":0.9990000128746033},{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/platelet-leukocyte-interaction","display_name":"platelet-leukocyte interaction","score":0.8769999742507935},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.9700000286102295},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.6650000214576721},{"id":"https://openalex.org/keywords/damage-associated-molecular-patterns","display_name":"damage-associated molecular patterns","score":0.6970000267028809},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.9236999750137329},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.7519999742507935},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6162999868392944},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5791000127792358},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.5773000121116638},{"id":"https://openalex.org/C2910274570","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative Disorders","level":2,"score":0.5537999868392944},{"id":"https://openalex.org/C2781236682","wikidata":"https://www.wikidata.org/wiki/Q410015","display_name":"TLR2","level":4,"score":0.5378999710083008},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.48350000381469727},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4742000102996826},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.4697999954223633},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4178999960422516},{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.4097999930381775},{"id":"https://openalex.org/C2107291","wikidata":"https://www.wikidata.org/wiki/Q14886885","display_name":"Mediator","level":2,"score":0.397599995136261},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3910999894142151},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.3781999945640564},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.37529999017715454},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.35420000553131104},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3531999886035919},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.35100001096725464},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3458000123500824},{"id":"https://openalex.org/C2779836521","wikidata":"https://www.wikidata.org/wiki/Q14914081","display_name":"TLR7","level":5,"score":0.3407999873161316},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.3221000134944916},{"id":"https://openalex.org/C32465701","wikidata":"https://www.wikidata.org/wiki/Q14914514","display_name":"Janus kinase 2","level":3,"score":0.31869998574256897},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3160000145435333},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.3057999908924103},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2980000078678131},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.29649999737739563},{"id":"https://openalex.org/C130523297","wikidata":"https://www.wikidata.org/wiki/Q14914487","display_name":"Tyrosine kinase 2","level":5,"score":0.28060001134872437},{"id":"https://openalex.org/C2776709828","wikidata":"https://www.wikidata.org/wiki/Q408004","display_name":"Toll-like receptor","level":4,"score":0.2581999897956848},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.25600001215934753}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051195","descriptor_name":"Toll-Like Receptor 2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D051195","descriptor_name":"Toll-Like Receptor 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3390/ijms27209083","doi":"https://doi.org/10.3390/ijms27209083","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ijms27209083","pdf_url":null,"source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},{"id":"doi:10.20944/preprints202609.0011.v1","doi":"https://doi.org/10.20944/preprints202609.0011.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202609.0011.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:13705039","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13705039/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13705039/pdf/ijms-27-09083.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Mol Sci","raw_type":"Text"},{"id":"pmid:42941857","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42941857","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of molecular sciences","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3390/ijms27209083","doi":"https://doi.org/10.3390/ijms27209083","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ijms27209083","pdf_url":null,"source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204988160.pdf","grobid_xml":"https://content.openalex.org/works/W7204988160.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1884746267","https://openalex.org/W1989739445","https://openalex.org/W2070099677","https://openalex.org/W2111141291","https://openalex.org/W2131861368","https://openalex.org/W2148574523","https://openalex.org/W2157415059","https://openalex.org/W2285491188","https://openalex.org/W2508261355","https://openalex.org/W2564597498","https://openalex.org/W2566525349","https://openalex.org/W2613996502","https://openalex.org/W2773899764","https://openalex.org/W2883319595","https://openalex.org/W2909022970","https://openalex.org/W2911435756","https://openalex.org/W2912561801","https://openalex.org/W3022595966","https://openalex.org/W3112914139","https://openalex.org/W4295347057","https://openalex.org/W4313572560","https://openalex.org/W4317662062","https://openalex.org/W4388723887","https://openalex.org/W4391110897","https://openalex.org/W4401457766","https://openalex.org/W4402849559"],"related_works":["https://openalex.org/W4401457766","https://openalex.org/W2568743403","https://openalex.org/W4389243427","https://openalex.org/W4310099119","https://openalex.org/W7166341973","https://openalex.org/W2501173461","https://openalex.org/W7203892759","https://openalex.org/W2980034346","https://openalex.org/W2728073471","https://openalex.org/W7169521083"],"abstract_inverted_index":{"Toll-like":[0],"receptor":[1,8],"2":[2],"(TLR2)":[3],"is":[4],"a":[5,62,82,127,151,154,158,229,256],"versatile":[6],"pattern-recognition":[7],"of":[9,54,66,130,141,215,252],"the":[10,138,212,242],"innate":[11],"immune":[12],"system":[13],"that":[14,35,78,107],"recognizes":[15],"both":[16],"pathogen-associated":[17],"molecular":[18,24],"patterns":[19,25],"(PAMPs)":[20],"and":[21,43,50,75,95,133,153,165,172,194,225],"endogenous":[22],"danger-associated":[23],"(DAMPs).":[26],"Philadelphia":[27],"chromosome-negative":[28],"myeloproliferative":[29],"neoplasms":[30],"(MPNs)-clonal":[31],"hematopoietic":[32],"stem-cell":[33],"disorders":[34],"include":[36],"essential":[37],"thrombocythemia":[38],"(ET),":[39],"polycythemia":[40],"vera":[41],"(PV),":[42],"myelofibrosis":[44],"(MF)-are":[45],"characterized":[46],"by":[47],"persistent":[48],"inflammation":[49,253],"an":[51,250],"increased":[52],"risk":[53],"thrombosis.":[55],"Dysregulated":[56],"TLR2":[57,79,131,201,205],"signaling":[58,192,206],"has":[59,176],"emerged":[60],"as":[61,150],"potentially":[63],"important":[64],"mediator":[65],"this":[67,123],"chronic":[68],"thrombo-inflammatory":[69,139,219,244],"state.":[70],"Findings":[71],"from":[72],"our":[73],"group":[74],"others":[76],"suggest":[77],"may":[80,188,195,209,227],"have":[81],"particularly":[83,170],"prominent":[84],"role":[85],"in":[86,98,111,167,179,207,246],"promoting":[87],"inflammatory":[88],"cytokine":[89],"production,":[90],"platelet-leukocyte":[91],"interactions,":[92],"endothelial":[93],"dysfunction,":[94],"thrombotic":[96],"complications":[97],"MPNs.":[99],"Our":[100],"findings":[101],"are":[102],"also":[103,196],"consistent":[104],"with":[105,143],"evidence":[106],"NF-\u03baB-mediated":[108],"proinflammatory":[109],"signaling,":[110],"addition":[112],"to":[113,119,137,199,217,248],"constitutive":[114],"JAK/STAT":[115],"activation,":[116],"contributes":[117],"substantially":[118],"MPN":[120,236],"pathogenesis.":[121],"In":[122],"review,":[124],"we":[125,240],"provide":[126],"comprehensive":[128],"overview":[129],"biology":[132],"examine":[134],"its":[135,147],"contribution":[136],"milieu":[140],"MPNs,":[142,169],"particular":[144],"emphasis":[145],"on":[146],"potential":[148],"utility":[149],"biomarker":[152],"therapeutic":[155,186,232],"target.":[156],"Ruxolitinib,":[157],"JAK1/2":[159],"inhibitor,":[160],"markedly":[161],"reduces":[162],"symptom":[163],"burden":[164],"splenomegaly":[166],"JAK2-mutant":[168],"PV":[171],"MF;":[173],"however,":[174,239],"it":[175],"limited":[177],"efficacy":[178],"CALR-mutant":[180],"or":[181],"triple-negative":[182],"ET.":[183],"This":[184],"differential":[185],"response":[187,245],"reflect":[189],"divergent":[190],"downstream":[191],"pathways":[193],"be":[197,249],"related":[198],"dysregulated":[200],"signaling.":[202],"Furthermore,":[203],"hyperactive":[204],"MPNs":[208,247],"help":[210],"explain":[211],"incomplete":[213],"ability":[214],"ruxolitinib":[216,226],"suppress":[218],"responses.":[220],"Therefore,":[221],"combined":[222],"TLR2-targeted":[223],"therapy":[224],"represent":[228],"more":[230],"effective":[231],"strategy":[233],"for":[234],"future":[235],"trials.":[237],"Overall,":[238],"consider":[241],"TLR2-mediated":[243],"amplifier":[251],"rather":[254],"than":[255],"primary":[257],"disease":[258],"driver.":[259]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-02T00:00:00"}